記錄引文

Citação APA (7ª ed.)
Perl, M., Herfeld, K., Harrer, D. C., Höpting, M., Schweiger, M., Sterz, U., . . . Fante, M. A. (2024). Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies. Ferrata Storti Foundation.
Citação do estilo Chicago (17ª ed.)
Perl, Markus, et al. Tocilizumab Administration in Cytokine Release Syndrome Is Associated with Hypofibrinogenemia After Chimeric Antigen Receptor T-cell Therapy for Hematologic Malignancies. Ferrata Storti Foundation, 2024.
Citação MLA (9ª ed.)
Perl, Markus, et al. Tocilizumab Administration in Cytokine Release Syndrome Is Associated with Hypofibrinogenemia After Chimeric Antigen Receptor T-cell Therapy for Hematologic Malignancies. Ferrata Storti Foundation, 2024.
警告：這些引文格式不一定是100％准確.